Mike Sexton retweeted
really great story theatlantic.com/science/arch…
Mike Sexton retweeted
Together in Olympic dreams - At the end of 19 days of competition, Team Ireland leave the stage with a record seven medals and having inspired millions back home #Paris2024 #Olympics

This media is unavailable
Mike Sexton retweeted
After decades of frustration and failed attempts, scientists might finally be on the cusp of developing therapies to restore immune ‘tolerance’ in conditions such as diabetes, lupus & multiple sclerosis. @nature nature.com/articles/d41586-0…
Mike Sexton retweeted
We opened our fourth office in Lisbon in six years yesterday. It was an honour to host former European Commissioner for Innovation & current Mayor of Lisbon Carlos @Moedas. We now have more than 90 full time staff in Portugal & will pass 100 soon. The office is beautiful ❤️
Mike Sexton retweeted
Did you know that you can track all public buses in Dublin? This map shows you the location of every bus, where it's going and even if it has USB ports!
bustimes.org/map#14/53.351/-…
Mike Sexton retweeted
NEW: housing shortages, affordability crises and NIMBYism are growing problems in many countries, but what’s especially striking is how much worse they all are in Anglophone countries 🇬🇧🇺🇸🇦🇺🇳🇿🇨🇦🇮🇪
What’s going on?
My column -> enterprise-sharing.ft.com/re…
With all respect to the current LLM AI conversation, *this* is the thing to watch. Incredible, if confirmed.
FUSION ENERGY BREAKTHROUGH: US scientists have made one of the most significant leaps in decades in the search for the Holy Grail of energy - limitless, carbon free power - by achieving net energy gain in a fusion reaction
ft.com/content/4b6f0fab-66ef…
Huge scoop by @thomas_m_wilson
Mike Sexton retweeted
Frank Wilhoit: “Conservatism consists of exactly one proposition …There must be in-groups whom the law protects but does not bind, alongside out-groups whom the law binds but does not protect.” This seems increasingly true.
This is incredible stuff.
“Five people with severe autoimmune disease have become the first in the world to receive a groundbreaking therapy that uses genetically altered cells to drive the illness into remission.” theguardian.com/science/2022… @guardian
Mike Sexton retweeted
*NEW* @ForbesTech #CES2022 digital was powered by Summit Engine, which @WebSummit started building for itself ten years ago. @paddycosgrave
t.ly/JgrH
Great analysis
Wrote some notes summarizing my first impressions of web3: moxie.org/2022/01/07/web3-fi…
Mike Sexton retweeted
It’s been a dream many years in the making that @WebSummit’s software would eventually power the world’s largest & best events like @CES
There’s been many nerds involved along the way, from our first engineers like @tonyennis & @Whelton, to our🥇adult engineer @jdfitzgerald 😝
Mike Sexton retweeted
Hope everyone is enjoying @CES online or in-person in Vegas. Congrats to the more than 50 engineers, designers, PMs & more at @WebSummit who are behind the online conference software, as well as the mobile app for those attending in person #CES2022
Mike Sexton retweeted
Good evening!
It’s that time of year again where I round up some things I thought were touching, lovely, silly or gas this year. God knows we could all do with the distraction right now 🤪🤪🤪
So sit back, relax and dive in. Hope you enjoy 💕
Mike Sexton retweeted
For the first time ever @WebSummit’s software (version 22.0.2) will help run someone else’s in-person event
It’s a big week for our little company as @CES mobile app has gone live
For those who can’t make it @CES online will also run on our virtual event platform launching Jan3
Mike Sexton retweeted
A little news
@WebSummit’s event software will power @CES, perhaps the world’s largest trade show, this January
More than 200,000 attendees & all exhibitors will rely on our platform
If @WebSummit’s software can power @CES, we think it can in time power any event on the planet
This is a big deal
💡BREAKING—New oral anti-viral drug *molnupiravir* cuts risk of #COVID19 hospitalization and death **in HALF** in a randomized trial. Results so astounding that the trial is being stopped early, and Merck plans to apply for emergency authorization ASAP. 🧵 washingtonpost.com/health/20…


























